ERBB2 and breast cancer: We also transiently overexpressed (for 24-168h) BRCA1/p220 in two none-/low-BRCA1/p220 expressing breast cancer cell lines, MDAMB468 (TN/BL) and SKBR3 (Her2+) (see Figure 1A).